文献速递骨肌技术与安全MR

腰椎MRI影像组学列线图检测多发性骨髓瘤微小残留病

Lumbar MR-based radiomics nomogram for detecting minimal residual disease in patients with multiple myeloma.
PubMed 文献 · Eur Radiol · 2023-03-28

本研究基于130例多发性骨髓瘤患者的腰椎MRI(T1WI和抑脂T2WI)提取影像组学特征,构建包含影像组学标签和游离轻链比值的列线图,用于检测治疗后微小残留病状态。列线图在训练集和测试集的AUC分别为0.980和0.903,表现出良好的检测性能。

要点

  • 腰椎MRI影像组学列线图可无创评估多发性骨髓瘤治疗后MRD状态。
  • 列线图综合了影像组学标签和游离轻链比值,训练集AUC 0.980、测试集0.903。
  • MRD状态对多发性骨髓瘤预后有强预测价值,影像组学有潜力辅助临床决策。

局限性

  • 样本量有限(130例),仅分训练集和测试集,未设外部验证集。
  • 单中心回顾性研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Minimal residual disease (MRD) is a standard for assessing treatment response in multiple myeloma (MM). MRD negativity is considered to be the most powerful predictor of long-term good outcomes. This study aimed to develop and validate a radiomics nomogram based on magnetic resonance imaging (MRI) of the lumbar spine to detect MRD after MM treatment.

METHODS: A total of 130 MM patients (55 MRD negative and 75 MRD positive) who had undergone MRD testing through next-generation flow cytometry were divided into a training set (n = 90) and a test set (n = 40). Radiomics features were extracted from lumbar spinal MRI (T1-weighted images and fat-suppressed T2-weighted images) by means of the minimum redundancy maximum relevance method and the least absolute shrinkage and selection operator algorithm. A radiomics signature model was constructed. A clinical model was established using demographic features. A radiomics nomogram incorporating the radiomics signature and independent clinical factor was developed using multivariate logistic regression analysis.

RESULTS: Sixteen features were used to establish the radiomics signature. The radiomics nomogram included the radiomics signature and the independent clinical factor (free light chain ratio) and showed good performance in detecting the MRD status (area under the curve: 0.980 in the training set and 0.903 in the test set).

CONCLUSIONS: The lumbar MRI-based radiomics nomogram showed good performance in detecting MRD status in MM patients after treatment, and it is helpful for clinical decision-making.

KEY POINTS: • The presence or absence of minimal residual disease status has a strong predictive significance for the prognosis of patients with multiple myeloma. • A radiomics nomogram based on lumbar MRI is a potential and reliable tool for evaluating minimal residual disease status in MM.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu, Wang, Zheng, et al. Lumbar MR-based radiomics nomogram for detecting minimal residual disease in patients with multiple myeloma. Eur Radiol. 2023. PMID: 36973432. doi:10.1007/s00330-023-09540-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。